Causes and Characteristics of Cancer - Part 2
CHELATION
Hydrogen Medicine
2 of 5
0% Complete
0/471 Steps

Oncology and Fraud

Much of oncology is based on research fraud. In a study published in Nature in March 2012, researchers tried to replicate the results of 53 basic pre-clinical cancer studies. Of those 53 studies, only six were replicable. In his new book, Bad Pharma, Dr. Goldacre sounds a warning bell on the fact that drug manufacturers are the ones who fund trials of their own products. One of the most widely recognized and true tests of scientific proof is when these studies showing positive results can be and are replicated by independent researchers—not researchers chosen or paid by the drug manufacturer providing the original finding.

“Drugs are tested by the people who manufacture them in poorly designed trials, on hopelessly small numbers of weird, unrepresentative patients, and analyzed using techniques that are flawed by design, in such a way that they exaggerate the benefits of treatments,” writes Goldacre. “When trials throw up results that companies don’t like, they are perfectly entitled to hide them from doctors and patients, so we only ever see a distorted picture of any drug’s true effects.”